Cyclobrachycoumarin from Gerbera piloselloides Inhibits Colorectal Cancer In Vitro and In Vivo
Molecules · 30.11.2024 · 29 (23) · 5678
DOI: 10.3390/molecules29235678 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 30.11.2024. Verfasst von Limei Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, School of Medicine, Jianghan University, Wuhan 430056, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Coumarins, Cell Proliferation, Apoptosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province, National Natural Science Foundation of China, Wuhan Science and Technology Project.
Abstract (Originalsprache)
Gerbera piloselloides, a plant in the Asteraceae family, is a traditional Chinese medicinal herb known for its unique therapeutic properties, including reported anti-tumor and antioxidant effects. Recent studies suggest that the main constitute of G. piloselloides, coumarins, may have potential anti-tumor activity. Recent research suggests that coumarins, the active compounds in G. piloselloides, may hold potential anti-tumor activity. However, the pharmacodynamic constituents remain unidentified. This study aims to isolate and characterize the bioactive compounds of G. piloselloides and to assess its anti-tumor effects. Initially, seven compounds, including coumarins, a ketone, and a furanolide, were isolated and identified from G. piloselloides by semi-preparative high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) analysis. The anti-tumor effects of these compounds were evaluated across four different cancer cell lines. Among them, the compound cyclobrachycoumarin showed a significant inhibitory effect on colorectal cancer (CRC) cell proliferation and was selected for further investigation. Cyclobrachycoumarin was found to induce CRC cell apoptosis and cell cycle arrest in a dose-dependent manner. This treatment also led to increased levels of ROS and cleaved PARP, along with decreased expressions of survivin, cyclin D1, and CDK1. In vivo studies further demonstrated that cyclobrachycoumarin effectively reduced tumor growth in HT-29 xenograft models by promoting apoptosis and cell cycle arrest, with a favorable tolerability profile. In summary, this study suggests that cyclobrachycoumarin may be a promising candidate for safe and effective CRC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Institute, School of Medicine, Jianghan University, Wuhan 430056, China.
- Hubei Key Laboratory of Cognitive and Affective Disorders, Wuhan Institute of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan 430056, China.
ORCID-Profile: Limei Fan, Haiping Wang, Xiaoying Hou, Yuchen Liu
Förderung
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
- Wuhan Science and Technology Project
- Research Fund of Jianghan University
Zitieren
APA
Fan, L., Ye, X., Fang, Q., Li, X., Wang, H., Sun, B., Shu, X., Hou, X., & Liu, Y. (2024). Cyclobrachycoumarin from Gerbera piloselloides Inhibits Colorectal Cancer In Vitro and In Vivo. Molecules, 29(23), 5678. https://doi.org/10.3390/molecules29235678
Vancouver
Fan L, Ye X, Fang Q, Li X, Wang H, Sun B, et al. Cyclobrachycoumarin from Gerbera piloselloides Inhibits Colorectal Cancer In Vitro and In Vivo. Molecules. 2024;29(23):5678. doi:10.3390/molecules29235678
BibTeX
@article{Fan2024,
author = {Fan, Limei and Ye, Xiansheng and Fang, Qian and Li, Xiaoxuan and Wang, Haiping and Sun, Binlian and Shu, Xiji and Hou, Xiaoying and Liu, Yuchen},
title = {Cyclobrachycoumarin from Gerbera piloselloides Inhibits Colorectal Cancer In Vitro and In Vivo},
journal = {Molecules},
year = {2024},
volume = {29},
number = {23},
pages = {5678},
doi = {10.3390/molecules29235678}
}
EUVIMED